4//SEC Filing
David Nathaniel E 4
Accession 0001140361-18-022047
CIK 0001463361other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 6:23 PM ET
Size
14.1 KB
Accession
0001140361-18-022047
Insider Transaction Report
Form 4
David Nathaniel E
DirectorPresident
Transactions
- Conversion
Common Stock
2018-05-07+1,074,032→ 2,054,878 total - Conversion
Common Stock
2018-05-07+222,148→ 2,277,026 total - Conversion
Common Stock
2018-05-07+1,630→ 2,278,656 total - Conversion
Series A-2 Preferred Stock
2018-05-07−1,074,032→ 0 total→ Common Stock (1,074,032 underlying) - Conversion
Series B Preferred Stock
2018-05-07−222,148→ 0 total→ Common Stock (222,148 underlying) - Conversion
Series C Preferred Stock
2018-05-07−1,630→ 0 total→ Common Stock (1,630 underlying)
Footnotes (2)
- [F1]The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.
- [F2]The expiration date is not relevant to the conversion of these securities.
Documents
Issuer
Unity Biotechnology, Inc.
CIK 0001463361
Entity typeother
Related Parties
1- filerCIK 0001559531
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 6:23 PM ET
- Size
- 14.1 KB